AI assistant
Glenmark Pharmaceuticals ltd — Regulatory Filings 2024
Feb 16, 2024
62608_rns_2024-02-16_240d7aba-d268-4433-9cde-7927616559d3.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [33 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
February 16, 2024
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q3 FY 2023-24 Earnings Call held on 16th February, 2024 on the website of the Company at: https://glenmark.bcdn.net/gpl_pdfs/investors/reports_presentations/earning_concall/Glenmark%20Pharma ceuticals%20Limited_%20Q3%20FY24_%20Earnings%20Call%20Recording.mp3.
Request you to kindly take the same on record.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Ltd.
HARISH Digitally signed by HARISH VINAYAK VINAYAK KUBER Date: 2024.02.16 KUBER 12:47:48 +05'30' Harish Kuber
Company Secretary & Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099, India T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]